Roquefort Therapeutics PLC 07 November 2024 7 November 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Conversion of Convertible Loan Notes Roquefort...
The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...
Roquefort Therapeutics PLC 27 September 2024 27 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Interim Results to 30 June 2024 Roquefort...
Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...
Roquefort Therapeutics PLC 23 September 2024 23 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Grant of Japan MK Cell Patent Roquefort Therapeutics...
Roquefort Therapeutics PLC 19 September 2024 19 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") STAT-6 siRNA Demonstrates Efficacy in Immunology ...
Roquefort Therapeutics PLC 02 September 2024 2 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Grant of MK Cell Patent & Licencing Update ...
Roquefort Therapeutics PLC 27 June 2024 27 June 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Results of AGM Roquefort Therapeutics (LSE:ROQ, OTCQB: ROQAF...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.4 | 10.1265822785 | 3.95 | 4.4 | 3.65 | 1511706 | 3.95816961 | DE |
4 | -0.1 | -2.24719101124 | 4.45 | 6.75 | 3.65 | 2437383 | 4.96745464 | DE |
12 | 0.65 | 17.5675675676 | 3.7 | 6.75 | 3.35 | 1075188 | 4.68564437 | DE |
26 | -0.9 | -17.1428571429 | 5.25 | 6.75 | 3.35 | 641166 | 4.63244715 | DE |
52 | -2.025 | -31.7647058824 | 6.375 | 9.25 | 3.35 | 457241 | 4.93543565 | DE |
156 | -8.15 | -65.2 | 12.5 | 12.5 | 3.35 | 330173 | 6.73256945 | DE |
260 | -1.65 | -27.5 | 6 | 13.5 | 3.35 | 274785 | 6.79733646 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관